Biostage, Inc. (BSTG) Files Form 4 Insider Buying : James Joseph Mcgorry Buys 10,000 Shares

Biostage, Inc. (BSTG): James Joseph Mcgorry , CEO of Biostage, Inc. purchased 10,000 shares on May 20, 2016. The Insider buying transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.56 per share for a total value of $15,600.00 , the company said in a SEC Form 4 Filing.

Company has been under the radar of several Street Analysts.Biostage, Inc. is Resumed by Maxim Group to Buy and the brokerage firm has set the Price Target at $8. The Rating was issued on Apr 7, 2016.

Leave a Reply

Biostage, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Biostage, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.